Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Imaging Studies VII: Vascular Imaging

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Indications and results of radioiodine treatment of differentiated thyroid cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2020

Same author

[PSMA radioligand therapy in patients with advanced prostate cancer].

Der Urologe. Ausg. A·2020

Same author

[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein].

Der Urologe. Ausg. A·2018

Same author

External radiation exposure, excretion, and effective half-life in <sup>177</sup>Lu-PSMA-targeted therapies.

EJNMMI research·2018

Same author

PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.

European journal of nuclear medicine and molecular imaging·2017

Same author

[<sup>177</sup>Lu-PSMA therapy : Current evidence for use in the treatment of patients with metastatic prostate cancer].

Der Urologe. Ausg. A·2017

Search research articles

Related Experiment Video

Updated: May 11, 2026

Multimodal Cross-Device and Marker-Free Co-Registration of Preclinical Imaging Modalities

Multimodal Cross-Device and Marker-Free Co-Registration of Preclinical Imaging Modalities

Published on: October 27, 2023

Multimodality molecular imaging--from target description to clinical studies.

O Schober¹, K Rahbar, B Riemann

¹Department of Nuclear Medicine, University Hospital Münster, Albert-Schweitzer-Str. 33, 48149, Münster, Germany. schober.otmar@uni-muenster.de

European Journal of Nuclear Medicine and Molecular Imaging

|January 9, 2009

Summary

The European Association of Nuclear Medicine (EANM) 2008 meeting highlighted advancements in molecular imaging and multimodality imaging. These trends are shaping the future of nuclear medicine, focusing on target identification through clinical evaluation.

More Related Videos

Multimodal Optical Imaging Platform for Studying Cellular Metabolism

Multimodal Optical Imaging Platform for Studying Cellular Metabolism

Published on: June 6, 2025

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Related Experiment Videos

Last Updated: May 11, 2026

Multimodal Cross-Device and Marker-Free Co-Registration of Preclinical Imaging Modalities

Multimodal Cross-Device and Marker-Free Co-Registration of Preclinical Imaging Modalities

Published on: October 27, 2023

Multimodal Optical Imaging Platform for Studying Cellular Metabolism

Multimodal Optical Imaging Platform for Studying Cellular Metabolism

Published on: June 6, 2025

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Area of Science:

Nuclear Medicine
Molecular Imaging
Multimodality Imaging

Background:

The 2008 European Association of Nuclear Medicine (EANM) Congress in Munich attracted over 4,000 participants.
A high volume of abstracts (1,597) were submitted, with a 14% rejection rate.
This review focuses on key trends from the top-scoring lectures.

Purpose of the Study:

To outline major findings and trends from the EANM 2008 Congress.
To highlight the increasing impact of molecular and multimodality imaging in nuclear medicine.
To structure the review around the steps of molecular imaging, from target to clinical studies.

Main Methods:

Selection of 100 high-scoring lectures from the EANM 2008 Congress.
Review of topics including targets, radiochemistry, radiopharmacy, devices, computer science, preclinical, and clinical evaluations.
Focus on the progression from molecular imaging to multimodality imaging.

Main Results:

Significant advancements in molecular imaging and multimodality imaging were presented.
The integration of molecular imaging into multimodality approaches is a key development.
The spectrum of nuclear medicine is increasingly defined by molecular imaging and therapy.

Conclusions:

Molecular imaging is a central theme in contemporary nuclear medicine.
The future of nuclear medicine lies in the advancement and integration of multimodality imaging.
EANM 2008 showcased the evolving landscape of nuclear medicine, emphasizing molecular and multimodality approaches.